Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation.

Baek, Jung Hwan; Kim, Yoon Suk; Sung, Jin Yong; Choi, Hoon; Lee, Jeong Hyun
AJR. American journal of roentgenology
2011Aug ; 197 ( 2 ) :W331-6.
ÀúÀÚ »ó¼¼Á¤º¸
Baek, Jung Hwan -
Kim, Yoon Suk -
Sung, Jin Yong -
Choi, Hoon -
Lee, Jeong Hyun -
ABSTRACT
OBJECTIVE: The purpose of this study was to evaluate the efficacy and safety of ultrasound-guided radiofrequency ablation (RFA) in the control of metastatic well-differentiated thyroid carcinoma in patients for whom surgery is not feasible. MATERIALS AND

METHODS: Between December 2004 and June 2008, 12 metastatic differentiated thyroid carcinomas (mean diameter, 13.8 mm; range, 4-28 mm) in 10 patients (six women, four men; mean age, 44.8 years) were treated with RFA. The inclusion criteria for RFA were fewer than three metastatic tumors confirmed with ultrasound-guided fine-needle aspiration biopsy, no metastatic tumor beyond the neck at RFA, and infeasibility of surgery. A radiofrequency generator and 18-gauge internally cooled electrodes with a 7-cm shaft length and 0.5- and 1-cm active tips were used depending on the size of the targeted tumors. Ten of the 12 metastatic tumors (83%) were treated in a single session of RFA, and the other two required two sessions. The ablation time ranged from 60 to 900 seconds.

RESULTS: After treatment, the mean largest diameter decreased significantly from 13.8 ± 7.0 mm to 3.3 ± 3.9 mm (p = 0.002), as did mean volume, from 55.5 ± 50.3 mm(3) to 5.7 ± 9.3 mm(3) (p = 0.002). At the last follow-up evaluation, the serum thyroglobulin concentration had decreased in 7 of 10 patients. One patient had dysphonia immediately after RFA of a left surgical bed. CONCLUSION: Although surgery is the standard treatment of locally metastatic thyroid cancer, RFA is effective for locoregional control of metastatic well-differentiated thyroid carcinoma in patients for whom surgery is infeasible.
na
MESH
Adult, Aged, Biopsy, Fine-Needle, Carcinoma, Papillary/pathology/*surgery/ultrasonography, Catheter Ablation/instrumentation/*methods, Electrodes, Equipment Design, Female, Humans, Lymphatic Metastasis, Male, Middle Aged, Neck Dissection, Retrospective Studies, Statistics, Nonparametric, Thyroid Neoplasms/pathology/*surgery/ultrasonography, Thyroidectomy, Treatment Outcome, *Ultrasonography, Interventional
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Ten of the 12 metastatic tumors (83%) were treated in a single session of RFA, and the other two required two sessions. The ablation time ranged from 60 to 900 seconds; RFA is effective for locoregional control of metastatic well-differentiated thyroid carcinoma in patients for whom surgery is infeasible.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.2214/AJR.10.5345
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå